ABG
DNLI icon

Ally Bridge Group’s Denali Therapeutics DNLI Stock Holding History

Ally Bridge Group’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,479
Closed -$125K – 26
2022
Q4 		$125K Buy
+4,479
New +$125K 0.12% 30